BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2006
View Archived Issues
Oregovomab under investigation in epithelial ovarian cancer
Read More
Inolimomab treatment in pediatric graft-versus-host disease reviewed
Read More
Nabi licenses ATG-Fresenius S for U.S. and Canada
Read More
Valera acquires rights to Valstar
Read More
Vaxon-Biotech and Institut Pasteur collaborate on cancer immunotherapy
Read More
Enrollment open in first pivotal study of cangrelor
Read More
Scynexis and Xsira design new selective GRK-2 inhibitors
Read More
Potent FXR antagonists from Amgen
Read More
Amazon Biotech preparing HIV studies for AMZ-0026
Read More
Bionomics receives Australian grant to advance vascular disruption agent
Read More
Innate Pharma and Novo Nordisk partner on drugs targeting natural killer cells
Read More
Phase III study of Efaproxyn cleared to continue
Read More
CytRx completes enrollment in phase IIa study of arimoclomol for ALS
Read More
QLT and Retinagenix sign agreement in retinal diseases
Read More
Cordis to establish global cardiac and vascular institute
Read More
OncoMethylome to participate in phase III study of temozolomide
Read More
Amorfix obtains rights to additional novel SOD1 targets
Read More
New phase II study evaluates OT-551 in geographic atrophy
Read More
Enrollment completed in phase I study of Provacel in heart attack patients
Read More
Viral Therapeutics changes name to Vybion
Read More
Duramed withdraws Lo Seasonale NDA
Read More
Roche presents novel and selective GlyT1 inhibitor as a candidate for schizophrenia
Read More
Unibioscreen develops novel lactosylated steroids with antimigratory activity against cancer cells
Read More
Wyeth selects potent Src kinase inhibitor from new series
Read More
PARP inhibitor simultaneously enhances antitumor activity and reduces neuropathy of cisplatin
Read More
Recent patents cover therapeutic agents for neurological disorders
Read More
New analgesic agents reported in recent patent literature
Read More
Novel tachykinin NK1 antagonists prepared and tested by Takeda
Read More
Novel potent fibrate analogues synthesized at Dr. Reddy's
Read More